NTLA
Intellia Therapeutics, Inc. · Healthcare
EVP and Chief Medical Officer David Lebwohl sold $96K of Intellia Therapeutics, Inc.
Sold$95,779
$37.21Price
2,574Shares
−9%Stake
What NTLA did after the filing
- The stock from Fri, Jan 6 close, $38.10
- −1.3%
- S&P 500, same days
- +2.8%
Measured over 30 trading days, to the Feb 21 close.
Traded Wed, Jan 4. Filed Fri, Jan 6, 12:26 PM ET, during the session. Returns use the Jan 6 close and the Feb 21 close. Not investment advice.